Investigation of transcription factor AP-2beta genotype in women with premenstrual dysphoric disorder

Neuroscience Letters

Volumn 377, Issue 1, 2005, Pages 49-52

  Damberg, Mattias ^a   Westberg, Lars ^b   Berggård, Cecilia ^a   Landen, Mikael ^b   Sundblad, Charlotta ^b   Eriksson, Olle ^a   Naessén, Tord ^a   Ekman, Agneta ^b   Eriksson, Elias ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5 HT; AP 2; Gene expression; Monoamines; Premenstrual dysphoria; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR AP 2;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RISK FACTOR;

EID: 13844266610     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.11.068     Document Type: Article

References (26)

1. J. Angst, R. Sellaro, K.R. Merikangas, and J. Endicott The epidemiology of perimenstrual psychological symptoms Acta Psychol. Scand. 104 2001 110 116
2. B.J. Bassam, G. Caetano-Anolles, and P.M. Gresshoff Fast and sensitive silver staining of DNA in polyacrylamide gels Anal. Biochem. 196 1991 80 83
3. A.J. Bond, J. Wingrove, and D.G. Critchlow Tryptophan depletion increases aggression in women during the prementrual phase Psychopharmacology 156 4 2001 477 480
4. J.H. Bream, M. Carrington, S. O'Toole, M. Dean, B. Gerrard, H.D. Shin, D. Kosack, W. Modi, H.A. Young, and M.W. Smith Polymorphisms of the human IFNG gene noncoding regions Immunogenetics 51 2000 50 58
5. A.A. Brzezinski, J.J. Wurtman, R.J. Wurtman, R. Gleason, J. Greenfield, and T. Nader d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression Obstet. Gynecol. 76 1990 296 301
6. C. Chazaud, M. Oulad-Abdelghani, P. Bouillet, D. Decimo, P. Chambon, and P. Dolle AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis Mech. Dev. 54 1996 83 94
7. J.T. Condon The premenstrual syndrome: a twin study Br. J. Psychiatry 162 1993 481 486
8. M. Damberg, C. Berggård, L. Farde, G.C. Sedvall, and E.G. Jönsson Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans J. Neural Transm. 111 4 2004 537 545
9. M. Damberg, C. Berggård, M. Mattila-Evenden, G. Rylander, K. Forslund, H. Garpenstrand, H. Bergman, J.P. Gustavsson, and E.G. Jönsson Transcription factor AP-2β genotype associated to anxiety-related personality traits in women - a replication study Neuropsychobiology 48 4 2003 169 175
10. M. Damberg, M. Eller, M. Tõnissaar, L. Oreland, and J. Harro Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain Neurosci. Lett. 313 2001 102 104
11. M. Damberg, H. Garpenstrand, J. Alfredsson, J. Ekblom, K. Forslund, G. Rylander, and L. Oreland A polymorphic region in the human transcription factor AP-2beta gene is associated with specific personality traits Mol. Psychiatry 5 2000 220 224
12. M. Damberg, H. Garpenstrand, C. Berggard, M. Åsberg, J. Hallman, and L. Oreland The genotype of human transcription factor AP-2beta is associated with platelet monoamine oxidase B activity Neurosci. Lett. 291 2000 204 206
13. M. Damberg, H. Garpenstrand, J. Hallman, and L. Oreland Genetic mechanisms of behavior - don't forget about the transcription factors Mol. Psychiatry 6 2001 503 510
14. E. Eriksson Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria Int. Clin. Psychopharmacol. 14 Suppl. 2 1999 27 33
15. E. Eriksson, B. Andersch, H.P. Ho, M. Landen, and C. Sundblad Diagnosis and treatment of premenstrual dysphoria J. Clin. Psychiatry 63 7 2002 16 23
16. E. Eriksson, M.A. Hedberg, B. Andersch, and C. Sundblad The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of prementrual syndrome Neuropsychopharmacology 12 1995 167 176
17. P.J. Mitchell, P.M. Timmons, J.M. Hebert, P.W. Rigby, and R. Tjian Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis Genes Dev. 5 1991 105 119
18. M. Moser, A. Imhof, A. Pscherer, R. Bauer, W. Amselgruber, F. Sinowatz, F. Hofstadter, R. Schule, and R. Buettner Cloning and characterization of a second AP-2 transcription factor: AP-2 beta Development 121 1995 2779 2788
19. M. Moser, A. Pscherer, C. Roth, J. Becker, G. Mucher, K. Zerres, C. Dixkens, J. Weis, L. Guay-Woodford, R. Buettner, and R. Fassler Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta Genes Dev. 11 1997 1938 1948
20. M.M. Müller, T. Gerster, and W. Schaffner Enhancer sequences and the regulation of gene transcription Eur. J. Biochem. 176 1988 485 495
21. J. Philipp, P.J. Mitchell, U. Malipiero, and A. Fontana Cell type-specific regulation of expression of transcription factor AP-2 in neuroectodermal cells Dev. Biol. 165 1994 602 614
22. R. Rosmond, and P. Björntorp Psychiatric ill-health of women and its relationship to obesity and body fat distribution Obes. Res. 6 1998 338 345
23. M. Steiner, S. Steinberg, D. Stewart, D. Carted, C. Berger, and R. Reid Fluoxetine in the treatment of premenstrual dysphoria N. Engl. J. Med. 332 1995 1529 1534
24. T. Williams, A. Admon, B. Luscher, and R. Tjian Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements Genes Dev. 2 1988 1557 1569
25. T. Williams, and R. Tjian Characterization of a dimerization motif in AP-2 and its function in heterologous DNA binding proteins Science 251 4997 1991 1067 1071
26. F. Zhao, M. Satoda, J.D. Licht, Y. Hayashizaki, and B.D. Gelb Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties J. Biol. Chem. 276 2001 40755 40760